RBC Capital analyst Deane Dray raised the firm’s price target on General Electric to $98 from $93 and keeps an Outperform rating on the shares. The analyst cites the company’s GE Healthcare analyst meeting presentation, which focused on its medium-term targets and initiatives to boost growth/margins across its four segments. Dray adds that the key positives from the even were how GE continues to be a leader in AI-enabled products and its 35% "new product vitality".
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GE: